Does riociguat improve exercise capacity in patients with pulmonary arterial hypertension?
Riociguat provides significant improvement in exercise capacity for patients with pulmonary arterial hypertension.
Riociguat significantly improved exercise capacity and secondary efficacy end points in patients with pulmonary arterial hypertension. (Funded by Bayer HealthCare; PATENT-1 and PATENT-2 ClinicalTrials.gov numbers, NCT00810693 and NCT00863681, respectively.).
Ghofrani et al. (2013) studied this question.